Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Private Payrolls Increased More Than Expected
12:11pm, Wednesday, 06'th May 2026
Pre-market futures are up nicely this morning as “Peace in the Middle East” once again grabs headlines. The U.S. has paused its three-day blockade at the Gulf of Oman, allowing for safe passage of
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
11:56am, Wednesday, 06'th May 2026
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before. Analysts have questioned whether Novo can remain a leader in the highly competitive market
Novo Nordisk beats profit forecasts on bumper Wegovy pill sales
11:36am, Wednesday, 06'th May 2026
Strong sales of Novo Nordisk's Wegovy pill helped the company beat first‑quarter earnings expectations and raise its full‑year outlook. CNBC's Ritika Gupta and Charlotte Reed break down the latest
ADP +109K: Job Growth on Lower-Paying Work
11:26am, Wednesday, 06'th May 2026
Beyond obvious strength in Healthcare, we're starting to see "green shoots" in industries that a year ago were seeing negative growth.
Novo Nordisk beats estimates, raises guidance on Wegovy pill surge
10:55am, Wednesday, 06'th May 2026
Novo Nordisk (NYSE:NVO) reported first-quarter results that far exceeded analyst estimates on Wednesday, driven by surging demand for its oral weight-loss pill and strong international sales. Net sale
Sales of Novo Nordisk's New Weight-Loss Pill Are Off To a Strong Start. The Stock Is Rising
10:11am, Wednesday, 06'th May 2026
Sales of Novo Nordisk's newest weight-loss drug are off to a strong start.
Novo Nordisk posts mixed quarter despite strong demand
09:53am, Wednesday, 06'th May 2026
Novo Nordisk (NVO) turned in a bit of a mixed quarter, with strong revenue growth but an earnings miss, even as it raised its full year outlook on continued dem
5 Things to Know Before the Stock Market Opens
09:06am, Wednesday, 06'th May 2026
Stock futures are surging as oil prices plunge amid optimism that the end of the Iran war could be in sight; a report this morning indicates that the U.S. and Iran are close to reaching a deal to end
Novo Raises Forecast as Wegovy Pill Fuels Sales
08:36am, Wednesday, 06'th May 2026
Novo Nordisk said this year's declines won't be as bad as initially expected thanks to the new Wegovy pill, which helped fuel sales in the first quarter. For the year, the worst drop for both profit a
Novo Nordisk Raises Outlook as GLP-1 Demand Stays Strong
08:15am, Wednesday, 06'th May 2026
Novo Nordisk (NVO, Financials) reported mixed results for the first quarter of 2026, with robust revenue growth countering weaker-than-expected earnings, while
The Billion-Dollar Women's Health Market Driving A New Endometriosis Focus
05:35am, Wednesday, 06'th May 2026
The commercial success of GLP-1 therapies has reshaped the economics of modern pharmaceuticals. What began as a treatment pathway for type 2 diabetes and obesity has evolved into one of the most lucra
Novo CEO: 80% of Wegovy weight-loss users new
04:48am, Wednesday, 06'th May 2026
Novo Nordisk CEO Mike Doustdar spoke with CNBC's Charlotte Reed about strong demand for its weight-loss drugs and a surge in new patients. 🔗Read more: cnb.cx/49ue5z8
Novo Nordisk CEO: Aim to expand U.S. weight-loss market
04:46am, Wednesday, 06'th May 2026
Mike Doustdar, CEO of Novo Nordisk, discusses the company's GLP-1 pill following the release of the company's Q1 earnings.
Novo Nordisk gains 7% on Q1 beat: is it too late to buy NVO stock?
04:35am, Wednesday, 06'th May 2026
Novo Nordisk's rebound got another lift on Wednesday after the Danish drugmaker delivered a first-quarter beat and showed that its new Wegovy pill is gaining traction faster than Wall Street expected.
Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history.
03:25am, Wednesday, 06'th May 2026
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
